These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10343237)

  • 1. Inoperable esophageal carcinoma.
    Caletti G; Fusaroli P; Villa-Gomez Roig G; De Groot KM; Nageshwar Reddy D
    Gastrointest Endosc; 1999 Jun; 49(6):814-6; discussion 816-7. PubMed ID: 10343237
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma.
    Pfau PR; Kochman ML
    Gastrointest Endosc; 2000 Oct; 52(4):583-6. PubMed ID: 11184142
    [No Abstract]   [Full Text] [Related]  

  • 3. EUS in advanced esophageal cancer.
    Penman ID; Shen EF
    Gastrointest Endosc; 2002 Oct; 56(4 Suppl):S2-6. PubMed ID: 12297740
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis, staging, and follow-up of esophageal cancer.
    Iyer RB; Silverman PM; Tamm EP; Dunnington JS; DuBrow RA
    AJR Am J Roentgenol; 2003 Sep; 181(3):785-93. PubMed ID: 12933482
    [No Abstract]   [Full Text] [Related]  

  • 5. Do physician attitudes and practices limit use of EUS in the staging and the treatment of esophageal carcinoma?
    McClave SA; Jones WF; Evans WB
    Gastrointest Endosc; 2005 Jun; 61(7):840-8. PubMed ID: 15933685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The indications for and results of palliative treatment in patients with esophageal and cardial carcinomas].
    Peracchia A; Segalin A; Bonavina L
    Ann Ital Chir; 1993; 64(6):651-6. PubMed ID: 7521599
    [No Abstract]   [Full Text] [Related]  

  • 7. [The problem of palliative endoprosthetic treatment of inoperable esophageal carcinoma].
    Sommer T; Kantartzis M; Garcia M; Letsch R
    Med Welt; 1982 Dec; 33(50):1810-1. PubMed ID: 6188023
    [No Abstract]   [Full Text] [Related]  

  • 8. Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.
    Gockel I; Kneist W; Junginger T
    World J Surg; 2006 Feb; 30(2):183-90. PubMed ID: 16425075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choices in treating carcinoma of the esophagus.
    Skinner DB
    Can J Surg; 1989 Nov; 32(6):420-3. PubMed ID: 2819618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging of esophageal carcinoma.
    Hagen JA; DeMeester TR
    J Thorac Cardiovasc Surg; 2003 May; 125(5):988-91. PubMed ID: 12771869
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative study of self-expandable metallic stent and bypass surgery for inoperable esophageal cancer.
    Aoki T; Osaka Y; Takagi Y; Okada R; Shinohara M; Tsuchida A; Sato S; Koyanagi Y
    Dis Esophagus; 2001; 14(3-4):208-11. PubMed ID: 11869321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endosonographic assessment of multimodality therapy predicts survival of oesophageal carcinoma patients.
    Eloubeidi MA; Wallace MB
    Gastrointest Endosc; 2001 Jul; 54(1):132-4. PubMed ID: 11447984
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic factors in definitive radiochemotherapy of advanced inoperable esophageal cancer.
    Semrau R; Herzog SL; Vallböhmer D; Kocher M; Hölscher AH; Müller RP
    Dis Esophagus; 2012 Aug; 25(6):545-54. PubMed ID: 22133297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of failure to cross esophageal tumors by endoluminal ultrasound.
    Morgan MA; Twine CP; Lewis WG; Lambe R; Oliphant HE; Robinson M; Crosby TD; Roberts SA
    Dis Esophagus; 2008; 21(6):508-13. PubMed ID: 18430190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized, multimodal palliative treatment of inoperable esophageal cancer: clinical impact of photodynamic therapy resulting in prolonged survival.
    Lindenmann J; Matzi V; Neuboeck N; Anegg U; Baumgartner E; Maier A; Smolle J; Smolle-Juettner FM
    Lasers Surg Med; 2012 Mar; 44(3):189-98. PubMed ID: 22334351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma.
    Willis J; Cooper GS; Isenberg G; Sivak MV; Levitan N; Clayman J; Chak A
    Gastrointest Endosc; 2002 May; 55(6):655-61. PubMed ID: 11979246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual cause of dysphagia and dyspnea.
    Torres J; Ferreira M; Raposo J; Mendes S; Ferreira R; Agostinho C; Mesquita R; Campos MJ
    Gastrointest Endosc; 2009 Sep; 70(3):584-5. PubMed ID: 19535049
    [No Abstract]   [Full Text] [Related]  

  • 19. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life.
    Madhusudhan C; Saluja SS; Pal S; Ahuja V; Saran P; Dash NR; Sahni P; Chattopadhyay TK
    Dis Esophagus; 2009; 22(4):331-6. PubMed ID: 19473211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging of oesophageal adenocarcinoma.
    Hardwick RH; Williams GT
    Br J Surg; 2002 Sep; 89(9):1076-7. PubMed ID: 12190670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.